Efficacy and safety results from CheckMate 140, a phase 2...

  • Main
  • 2020 / 08
  • Efficacy and safety results from CheckMate 140, a phase 2...

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

Armand, Philippe, Janssens, Ann MH, Gritti, Giuseppe, Radford, John, Timmerman, John M, Pinto, Antonio, Mercadal Vilchez, Santiago, Johnson, P. W. M., Cunningham, David, Leonard, John P, Rodig, Scott
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Blood
DOI:
10.1182/blood.2019004753
Date:
August, 2020
File:
PDF, 391 KB
2020
Conversion to is in progress
Conversion to is failed